Fortinet FTNT Q1 2026 Beat Revenue NA EPS Exceeds by Significant WD40 Company WDFC Unchanged at 20158 RangeBound Trading 20260515 WaterBridge WBI Crushes Q4 2025 Estimates EPS 017 Tops Views Global Markets Eye Potential TrumpXi Summit as Trade War Uncertainty Lingers Corporate Interest in Prediction Markets Remains Strong Despite Regulatory Uncertainty FTSE 100 Breaks FourWeek Losing Streak as Softer Inflation and Weak Retail Sales Ease Rate Hike Concerns Piper Sandler Highlights Potential Pressure on Tractor Supply TSCO Amid Weak Pet Spending Trends US Groups Call for Investigation into Robloxs Child Safety and Spending Practices Trump Seeks Totally Independent New Fed Chair Escalates Pressure on Powells Legacy Consumer Sentiment Plunges to Record Low in May as Gas Prices Surge Amid Iran Conflict GECC Q1 2026 Earnings EPS Beats Estimates by 126 Amid Stable Operations NMFC Q1 2026 Earnings Narrowly Misses EPS Estimates Amid Stable Operations Certara Inc CERT Q1 2026 Earnings EPS Misses Estimates as Stock Rises on Solid Operational Progress CCM Q2 2016 Earnings Misses EPS Estimates by Wide Margin CART Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction FRAF Q1 2026 Earnings EPS Surpasses Estimates by 828 Stock Edges Lower BXP Inc Holds Steady Near 60 Support and Resistance Levels in Focus New America Acquisition I Corp NWAX Holds Steady at 1013 A Test of Stability Redwood Trust Senior Notes RWTN Ascend to 2503 Nearing Resistance on Income Demand Exagen Inc XGN Holds Steady Near Support Amid Low Volatility Zevia PBC ZVIA Declines 76 as Shares Test Key Support Zone Ashland Inc ASH Q1 2026 Earnings EPS Misses Estimates Amid Challenging Market Conditions HIND Q1 2026 Earnings EPS Beats Estimates Despite Revenue Absence PNTG Q1 2026 Earnings Modest EPS Beat Fails to Lift Stock Recursion Pharmaceuticals RXRX Q1 2026 Earnings Narrower Loss Surprises Market but Stock Dips on PreRevenue Status RRC Q1 2026 Earnings Strong EPS Beat Driven by Cost Discipline and Operational Efficiency Tracker Mortgages Regain Popularity Amid Uncertain Rate Outlook Evaluating the Pros and Cons Copa Holdings Q1 2026 Earnings Strong EPS Beat Highlights Operational Resilience Centessa Pharmaceuticals CNTA Holds Steady Near Resistance as Traders Weigh Catalysts